Aurélie Cazes

5.9k total citations · 1 hit paper
108 papers, 3.8k citations indexed

About

Aurélie Cazes is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Aurélie Cazes has authored 108 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 27 papers in Surgery. Recurrent topics in Aurélie Cazes's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Lung Cancer Treatments and Mutations (23 papers) and Lung Cancer Diagnosis and Treatment (13 papers). Aurélie Cazes is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Lung Cancer Treatments and Mutations (23 papers) and Lung Cancer Diagnosis and Treatment (13 papers). Aurélie Cazes collaborates with scholars based in France, United States and Germany. Aurélie Cazes's co-authors include Marc Riquet, Stéphane Germain, Pierre Corvol, Françoise Le Pimpec‐Barthes, Sébastien Le Jan, Catherine Monnot, Josette Philippe, Diane Damotte, Bruno Crestani and Antoine M. Dujon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Aurélie Cazes

102 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

2015 356 citations Nicolás A. Giraldo, Étienne Becht et al. Clinical Cancer Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Aurélie Cazes	1.6k	1.5k	957	727	627	108	3.8k
Hiroyasu Yokomise	2.2k 1.3×	1.1k 0.7×	1.2k 1.2×	434 0.6×	360 0.6×	220	4.5k
Zan Shen	1.0k 0.6×	1.2k 0.8×	1.2k 1.3×	632 0.9×	253 0.4×	155	3.1k
Thomas Knösel	1.2k 0.7×	1.6k 1.1×	1.5k 1.6×	618 0.9×	331 0.5×	176	4.3k
Tomohiko Asano	804 0.5×	1.0k 0.7×	1.5k 1.6×	635 0.9×	256 0.4×	180	3.6k
Bruce Pawel	1.7k 1.0×	1.3k 0.8×	2.2k 2.3×	984 1.4×	351 0.6×	139	5.1k
Paul A. VanderLaan	2.1k 1.3×	1.3k 0.9×	630 0.7×	612 0.8×	392 0.6×	150	4.1k
Vincent de Montpréville	1.5k 0.9×	1.2k 0.8×	586 0.6×	236 0.3×	706 1.1×	142	4.3k
Jaime R. Merchan	2.1k 1.3×	1.9k 1.3×	2.3k 2.4×	1.5k 2.0×	1.6k 2.6×	140	7.4k
Makoto Sonobe	2.8k 1.7×	1.5k 1.0×	780 0.8×	478 0.7×	244 0.4×	224	4.8k
Yutaka Takeda	1.3k 0.8×	2.0k 1.3×	1.5k 1.6×	1.2k 1.7×	295 0.5×	311	5.3k

Countries citing papers authored by Aurélie Cazes

Since Specialization

Citations

This map shows the geographic impact of Aurélie Cazes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Cazes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Cazes more than expected).

Fields of papers citing papers by Aurélie Cazes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Cazes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Cazes. The network helps show where Aurélie Cazes may publish in the future.

Co-authorship network of co-authors of Aurélie Cazes

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Cazes. A scholar is included among the top collaborators of Aurélie Cazes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Cazes. Aurélie Cazes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Debray, Marie‐Pierre, Almerico Marruchella, Aurélie Cazes, et al.. (2024). Cystic lung in sarcoidosis: Clinico‐radiologic characteristic and evolution. Respirology. 29(12). 1067–1076.

Borie, Raphaël, Laureline Berteloot, Caroline Kannengiesser, et al.. (2024). Rare genetic interstitial lung diseases: a pictorial essay. European Respiratory Review. 33(174). 240101–240101. 5 indexed citations

Archer, Gabrielle, A. Justet, Madeleine Jaillet, et al.. (2024). FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(3). 486–498. 4 indexed citations

Justet, A., Madeleine Jaillet, Eirini Vasarmidi, et al.. (2024). Identification of FGFR4 as a regulator of myofibroblast differentiation in pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 327(6). L818–L830. 1 indexed citations

Cazes, Aurélie, Jonathan Messika, Philippe Montravers, et al.. (2023). A 24-Year-Old Woman With Cough, Arthralgia, and Skin Ulcerations. CHEST Journal. 163(5). e223–e229. 1 indexed citations

Justet, A., Eirini Vasarmidi, Madeleine Jaillet, et al.. (2022). FGF19 is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 67(2). 173–187. 13 indexed citations

Gounant, V., M. Duruisseaux, Olivier Bylicki, et al.. (2021). Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients. Cancers. 13(5). 1040–1040. 9 indexed citations

Assoun, Sandra, Nathalie Théou–Anton, Aurélie Cazes, et al.. (2019). Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer. Lung Cancer. 132. 65–71. 117 indexed citations

Adam, Julien, Véronique Hofman, Audrey Mansuet‐Lupo, et al.. (2019). P2.09-17 Real-World Concordance Across Pathologists for PD-L1 Scoring in Non-Small Cell Lung Cancer: Results from a Large Nationwide Initiative. Journal of Thoracic Oncology. 14(10). S775–S775. 7 indexed citations

10.

Beltramo, Guillaume, Gabriel Thabut, Nicolas Péron, et al.. (2018). Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients. Respiratory Medicine. 135. 15–21. 4 indexed citations

11.

Brayer, Stéphanie, Audrey Joannes, Madeleine Jaillet, et al.. (2017). The pro-apoptotic BAX protein influences cell growth and differentiation from the nucleus in healthy interphasic cells. Cell Cycle. 16(21). 2108–2118. 19 indexed citations

12.

Giraldo, Nicolás A., Étienne Becht, Franck Pagès, et al.. (2015). Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer. Clinical Cancer Research. 21(13). 3031–3040. 356 indexed citations breakdown →

13.

Reyniès, Aurélien de, Marie‐Claude Jaurand, Annie Renier, et al.. (2014). Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition. Clinical Cancer Research. 20(5). 1323–1334. 100 indexed citations

14.

Remark, Romain, Marco Alifano, Isabelle Cremer, et al.. (2013). Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin. Clinical Cancer Research. 19(15). 4079–4091. 284 indexed citations

15.

Vieira, Thibault, Nicolas Girard, Mony Ung, et al.. (2013). Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma. Journal of Thoracic Oncology. 8(12). 1574–1577. 155 indexed citations

16.

Godet, Yann, Elizabeth Fabre, Magalie Dosset, et al.. (2012). Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response. Clinical Cancer Research. 18(10). 2943–2953. 76 indexed citations

17.

Boddaert, Guillaume, et al.. (2012). Bronchial Carcinoid Tumors Causing Cushing's Syndrome: More Aggressive Behavior and the Need for Early Diagnosis. The Annals of Thoracic Surgery. 94(6). 1823–1829. 29 indexed citations

18.

Didelot, Audrey, Delphine Le Corre, Armelle Luscan, et al.. (2012). Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Experimental and Molecular Pathology. 92(3). 275–280. 91 indexed citations

19.

Loupy, Alexandre, Aurélie Cazes, R. Guillemain, et al.. (2011). Very Late Heart Transplant Rejection Is Associated with Microvascular Injury, Complement Deposition and Progression to Cardiac Allograft Vasculopathy. American Journal of Transplantation. 11(7). 1478–1487. 63 indexed citations

20.

Jan, Sébastien Le, Aurélie Cazes, Catherine Monnot, et al.. (2003). Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma. American Journal Of Pathology. 162(5). 1521–1528. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact